Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
Tactile Systems Technology (TCMD) has announced it will release its first quarter fiscal year 2025 financial results after market close on Monday, May 5, 2025. The company will host a conference call with Q&A at 5:00 p.m. Eastern Time on the same day.
Participants can join via phone (877-407-3088 for domestic, 201-389-0927 for international) using access code 13752588. A live webcast will be available on the company's investor relations website, with a two-week replay available afterward.
Tactile Medical specializes in at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, focusing on improving patient self-care capabilities.
Tactile Systems Technology (TCMD) ha annunciato che pubblicherà i risultati finanziari del primo trimestre dell'anno fiscale 2025 dopo la chiusura del mercato di lunedì 5 maggio 2025. La società terrà una conference call con sessione di domande e risposte alle 17:00 ora della costa orientale degli Stati Uniti nello stesso giorno.
I partecipanti potranno collegarsi telefonicamente (877-407-3088 per chiamate nazionali, 201-389-0927 per chiamate internazionali) utilizzando il codice di accesso 13752588. Sarà disponibile anche una diretta web sul sito dedicato agli investitori della società, con la possibilità di rivedere la registrazione per due settimane successive.
Tactile Medical è specializzata in terapie domiciliari per patologie croniche come linfedema, lipedema, insufficienza venosa cronica e malattie polmonari croniche, con un focus sul miglioramento dell’autonomia del paziente nella gestione della propria cura.
Tactile Systems Technology (TCMD) ha anunciado que publicará sus resultados financieros del primer trimestre del año fiscal 2025 después del cierre del mercado el lunes 5 de mayo de 2025. La compañía realizará una llamada conferencia con sesión de preguntas y respuestas a las 5:00 p.m., hora del Este, ese mismo día.
Los participantes pueden unirse por teléfono (877-407-3088 para llamadas nacionales, 201-389-0927 para internacionales) usando el código de acceso 13752588. También habrá una transmisión en vivo disponible en el sitio web de relaciones con inversores de la empresa, con una repetición disponible durante dos semanas después.
Tactile Medical se especializa en terapias domiciliarias para condiciones crónicas como linfedema, lipedema, insuficiencia venosa crónica y enfermedades pulmonares crónicas, enfocándose en mejorar la capacidad del paciente para el autocuidado.
Tactile Systems Technology (TCMD)는 2025 회계연도 1분기 재무 결과를 2025년 5월 5일 월요일 시장 마감 후 발표할 예정입니다. 회사는 같은 날 동부 표준시 오후 5시에 질의응답이 포함된 컨퍼런스 콜을 진행합니다.
참석자는 전화(국내: 877-407-3088, 국제: 201-389-0927)를 통해 접속 코드 13752588을 사용하여 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트도 제공되며, 이후 2주간 다시보기 서비스가 가능합니다.
Tactile Medical은 림프부종, 지방부종, 만성 정맥 기능 부전, 만성 폐질환 등 만성 질환에 대한 가정 치료를 전문으로 하며, 환자의 자가 관리 능력 향상에 중점을 두고 있습니다.
Tactile Systems Technology (TCMD) a annoncé qu’elle publiera ses résultats financiers du premier trimestre de l’exercice 2025 après la clôture des marchés le lundi 5 mai 2025. La société tiendra une conférence téléphonique avec une séance de questions-réponses à 17h00, heure de l’Est, le même jour.
Les participants peuvent se joindre par téléphone (877-407-3088 pour les appels nationaux, 201-389-0927 pour les appels internationaux) en utilisant le code d’accès 13752588. Une webdiffusion en direct sera disponible sur le site des relations investisseurs de la société, avec un replay accessible pendant deux semaines ensuite.
Tactile Medical est spécialisée dans les thérapies à domicile pour les affections chroniques telles que le lymphœdème, le lipœdème, l’insuffisance veineuse chronique et les maladies pulmonaires chroniques, en mettant l’accent sur l’amélioration de l’autonomie des patients dans leur prise en charge.
Tactile Systems Technology (TCMD) hat angekündigt, seine Finanzergebnisse für das erste Quartal des Geschäftsjahres 2025 nach Börsenschluss am Montag, den 5. Mai 2025, zu veröffentlichen. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz mit Fragerunde abhalten.
Teilnehmer können telefonisch teilnehmen (877-407-3088 für Inland, 201-389-0927 für international) und den Zugangscode 13752588 verwenden. Ein Live-Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit einer zweiwöchigen Wiedergabemöglichkeit danach.
Tactile Medical ist auf häusliche Therapien für chronische Erkrankungen wie Lymphödem, Lipödem, chronische venöse Insuffizienz und chronische Lungenerkrankungen spezialisiert und konzentriert sich darauf, die Selbstpflegefähigkeiten der Patienten zu verbessern.
- None.
- None.
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 5, 2025, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13752588. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13752588. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When will Tactile Medical (TCMD) report Q1 2025 earnings?
How can investors access TCMD's Q1 2025 earnings call?
What medical conditions does Tactile Medical (TCMD) treat?
Where can I find the replay of TCMD's Q1 2025 earnings call?
